Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Hohnloser

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
European Heart Journal|September 1, 1989
Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre studyA Geibel, T Meinertz, M Zehender, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research GroupM Zehender, T Meinertz, S Hohnloser, et al.
The American Journal of Cardiology|April 1, 1989
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserinM Zehender, T Meinertz, S Hohnloser, et al.
Zeitschrift Fur Kardiologie|September 1, 1994
[Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy]D Horstkotte, S Hohnloser, F Keller, et al.
American Heart Journal|December 1, 1988
Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinantsT Hofmann, T Meinertz, W Kasper, et al.
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1984
[Prognostic significance of the QT-interval following myocardial infarction]M H Hust, S Heilmann, T Bonzel, et al.
Herzschrittmachertherapie & Elektrophysiologie|December 18, 2007
[Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference]P Kirchhof, A Goette, G Hindricks, et al.
Klinische Wochenschrift|January 1, 1988
Coronary thrombolysis in man with pro-urokinase: improved efficacy with low dose urokinaseW Kasper, T Meinertz, S Hohnloser, et al.
Circulation|June 1, 1995
More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID InvestigatorsR W Smalling, C Bode, J Kalbfleisch, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 27, 2001
Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncopeM Brignole, P Alboni, D Benditt, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
European Heart Journal|September 1, 1989
Antiarrhythmic efficacy and tolerance of oral propafenone in patients with frequent ventricular arrhythmias: experience of a multicentre studyA Geibel, T Meinertz, M Zehender, et al.
Clinical Physiology and Biochemistry|January 1, 1990
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserin. Multicenter Ketanserin Research GroupM Zehender, T Meinertz, S Hohnloser, et al.
The American Journal of Cardiology|April 1, 1989
Incidence and clinical relevance of QT prolongation caused by the new selective serotonin antagonist ketanserinM Zehender, T Meinertz, S Hohnloser, et al.
Zeitschrift Fur Kardiologie|September 1, 1994
[Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy]D Horstkotte, S Hohnloser, F Keller, et al.
American Heart Journal|December 1, 1988
Mode of death in idiopathic dilated cardiomyopathy: a multivariate analysis of prognostic determinantsT Hofmann, T Meinertz, W Kasper, et al.
Schweizerische Medizinische Wochenschrift. Supplementum|January 1, 1984
[Prognostic significance of the QT-interval following myocardial infarction]M H Hust, S Heilmann, T Bonzel, et al.
Herzschrittmachertherapie & Elektrophysiologie|December 18, 2007
[Outcome parameters for AF trials--executive summary of an AFNET-EHRA consensus conference]P Kirchhof, A Goette, G Hindricks, et al.
Klinische Wochenschrift|January 1, 1988
Coronary thrombolysis in man with pro-urokinase: improved efficacy with low dose urokinaseW Kasper, T Meinertz, S Hohnloser, et al.
Circulation|June 1, 1995
More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID InvestigatorsR W Smalling, C Bode, J Kalbfleisch, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|October 27, 2001
Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncopeM Brignole, P Alboni, D Benditt, et al.
Pageof 6